Brahma Capital

Brahma Capital operates as a private investment firm, strategically deploying capital across biotechnology, special situations, and public markets. The firm’s core approach involves identifying transformative companies led by proven management teams, aiming for outsized returns. It focuses on inefficient sectors, actively investing in opportunities poised for significant inflection points.

Sundeep Agrawal, MD, established Brahma Capital in 2019, founding the firm with the insight that private deals can significantly outperform public market returns. Dr. Agrawal, a former General Partner at Colt Ventures and Vice President at Longitude Capital, leverages his extensive background in healthcare investment banking and clinical medicine to inform the firm’s specialized strategy.

Brahma Capital partners with strategic capital and premier biotech investment firms, channeling resources into companies within its focused sectors. The firm’s long-term vision centers on patiently sourcing impactful deals through its extensive network, believing that concentrated investments in carefully selected opportunities will ultimately yield the highest returns.